Annual Total Long Term Liabilities
$7.40 M
-$258.00 K-3.37%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual total long term liabilities is $7.40 million, with the most recent change of -$258.00 thousand (-3.37%) on December 31, 2023.
- During the last 3 years, AVIR annual total long term liabilities has risen by +$7.36 million (+20455.56%).
- AVIR annual total long term liabilities is now -89.32% below its all-time high of $69.26 million, reached on December 31, 2018.
Performance
AVIR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$7.25 M
-$49.00 K-0.67%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly total long term liabilities is $7.25 million, with the most recent change of -$49.00 thousand (-0.67%) on September 30, 2024.
- Over the past year, AVIR quarterly long term liabilities has dropped by -$206.00 thousand (-2.76%).
- AVIR quarterly long term liabilities is now -95.88% below its all-time high of $175.80 million, reached on September 30, 2020.
Performance
AVIR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AVIR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | -2.8% |
| 3 y3 years | +10000.0% | -2.8% |
| 5 y5 years | -89.3% | -2.8% |
AVIR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.4% | +24.8% | -17.4% | +22.1% |
| 5 y | 5-year | -89.3% | >+9999.0% | -95.9% | -100.0% |
| alltime | all time | -89.3% | >+9999.0% | -95.9% | -100.0% |
Atea Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.25 M(-0.7%) |
| Jun 2024 | - | $7.29 M(-0.7%) |
| Mar 2024 | - | $7.35 M(-0.7%) |
| Dec 2023 | $7.40 M(-3.4%) | $7.40 M(-0.7%) |
| Sep 2023 | - | $7.45 M(-0.9%) |
| Jun 2023 | - | $7.52 M(-0.9%) |
| Mar 2023 | - | $7.59 M(-0.9%) |
| Dec 2022 | $7.66 M | $7.66 M(-1.3%) |
| Sep 2022 | - | $7.75 M(-11.6%) |
| Jun 2022 | - | $8.77 M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.70 M(+46.6%) |
| Dec 2021 | $5.93 M(>+9900.0%) | $5.93 M(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $29.00 K(-74.3%) |
| Mar 2021 | - | $113.00 K(+213.9%) |
| Dec 2020 | $36.00 K(-99.9%) | $36.00 K(-100.0%) |
| Sep 2020 | - | $175.80 M(>+9900.0%) |
| Jun 2020 | - | $69.00 K(-99.9%) |
| Dec 2019 | $69.21 M(-0.1%) | $69.21 M |
| Dec 2018 | $69.26 M | - |
FAQ
- What is Atea Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Atea Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Atea Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AVIR is $7.40 M
What is the all time high annual total long term liabilities for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual total long term liabilities is $69.26 M
What is Atea Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AVIR annual total long term liabilities has changed by -$258.00 K (-3.37%)
What is Atea Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AVIR is $7.25 M
What is the all time high quarterly long term liabilities for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly total long term liabilities is $175.80 M
What is Atea Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AVIR quarterly total long term liabilities has changed by -$206.00 K (-2.76%)